• Users Online: 505
  • Print this page
  • Email this page

    Article Cited by others

DRUG PROFILE

Vismodegib: A smoothened inhibitor for the treatment of advanced basal cell carcinoma

Aditya Suruchi, Rattan Aditya

Year : 2013| Volume: 4| Issue : 4 | Page no: 365-368

   This article has been cited by
 
1 Effect of salinomycin on EMT and stemness pathways in 5-FU-resistant breast cancer
Divya Sivanesan, Raj Pranap Arun, Rama Shanker Verma
Advances in Cancer Biology - Metastasis. 2021; 1: 100004
[Pubmed]  [Google Scholar] [DOI]
2 Metformin is associated with decreased risk of basal cell carcinoma: A whole-population case-control study from Iceland
Jonas A. Adalsteinsson, Sonal Muzumdar, Reid Waldman, Rong Wu, Désirée Ratner, Hao Feng, Jonathan Ungar, Jonathan I. Silverberg, Gudridur H. Olafsdottir, Arni Kjalar Kristjansson, Laufey Tryggvadottir, Jon Gunnlaugur Jonasson
Journal of the American Academy of Dermatology. 2021; 85(1): 56
[Pubmed]  [Google Scholar] [DOI]
3 Vismodegib anticancer drug: Analyzing electronic and structural features and examining biological activities
Tahereh Mohseniabbasabadi, Farnoosh Behboodyzad, Firoozeh Abolhasani Zadeh, Ebrahim Balali
Main Group Chemistry. 2021; : 1
[Pubmed]  [Google Scholar] [DOI]
4 Hedgehog Pathway Inhibitors against Tumor Microenvironment
Silpa Gampala, Jer-Yen Yang
Cells. 2021; 10(11): 3135
[Pubmed]  [Google Scholar] [DOI]
5 A Drug Screening Pipeline Using 2D and 3D Patient-Derived In Vitro Models for Pre-Clinical Analysis of Therapy Response in Glioblastoma
Sakthi Lenin, Elise Ponthier, Kaitlin G. Scheer, Erica C. F. Yeo, Melinda N. Tea, Lisa M. Ebert, Mariana Oksdath Mansilla, Santosh Poonnoose, Ulrich Baumgartner, Bryan W. Day, Rebecca J. Ormsby, Stuart M. Pitson, Guillermo A. Gomez
International Journal of Molecular Sciences. 2021; 22(9): 4322
[Pubmed]  [Google Scholar] [DOI]
6 Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis
Daniel Doheny, Sherona Sirkisoon, Richard L. Carpenter, Noah Reeve Aguayo, Angelina T. Regua, Marlyn Anguelov, Sara G. Manore, Austin Arrigo, Sara Abu Jalboush, Grace L. Wong, Yang Yu, Calvin J. Wagner, Michael Chan, Jimmy Ruiz, Alexandra Thomas, Roy Strowd, Jiayuh Lin, Hui-Wen Lo
Oncogene. 2020; 39(42): 6589
[Pubmed]  [Google Scholar] [DOI]
7 Phosphoproteomics of short-term hedgehog signaling in human medulloblastoma cells
Tamara Scheidt, Oliver Alka, Humberto Gonczarowska-Jorge, Wolfgang Gruber, Florian Rathje, Margherita Dell’Aica, Marc Rurik, Oliver Kohlbacher, René P. Zahedi, Fritz Aberger, Christian G. Huber
Cell Communication and Signaling. 2020; 18(1)
[Pubmed]  [Google Scholar] [DOI]
8 Development of taladegib as a sonic hedgehog signaling pathway inhibitor
Guanghai Jin,Aneesh Sivaraman,Kyeong Lee
Archives of Pharmacal Research. 2017; 40(12): 1390
[Pubmed]  [Google Scholar] [DOI]
9 Deciphering structural stability and binding mechanisms of potential antagonists with smoothened protein
Noopur Sinha,Saikat Chowdhury,Ram Rup Sarkar
Journal of Biomolecular Structure and Dynamics. 2017; : 1
[Pubmed]  [Google Scholar] [DOI]
10 Large Nodular Growth on the Nose
Neha Chandan,Stephanie Wang
Journal of the Dermatology Nurses’ Association. 2017; : 1
[Pubmed]  [Google Scholar] [DOI]
11 The Hedgehog Signaling Pathway Emerges as a Pathogenic Target
Margery Smelkinson
Journal of Developmental Biology. 2017; 5(4): 14
[Pubmed]  [Google Scholar] [DOI]
12 Merkel Cell Carcinoma with a Suppressor of Fused (SUFU) Mutation: Case Report and Potential Therapeutic Implications
Philip R. Cohen,Razelle Kurzrock
Dermatology and Therapy. 2015;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article